Reatment in the PHC (US 52) compared to inpatient hospitals (US 47) as the price of VL treatment at PHC integrated the cost of administering Glucantime. The hospitalization charges were more than two occasions greater in inpatient (US 357) than outpatient (US 154) hospitals. Nevertheless, in each methods these costs represent 52 on the total charges. The cost of tests (other than VL diagnosis) represented 24 in inpatient care in comparison with 12 making use of outpatient strategy. Bootstrap procedures confirmed that final results assessed the highest degree of energy on all comparisons undertook (Table 3). The median cost of a day in hospital was US 32 (mean of US 33) when the data from all hospitals was pooled collectively. This expense was substantially larger in hospitals following anPLOS One | DOI:10.1371/journal.pone.0155482 June 3,eight /Cost of Pediatric Visceral Leishmaniasis Care in MoroccoTable 3. Fees of pediatric visceral leishmaniasis (VL) care in Morocco (US ). Total fees and fees divided by category (VL diagnosis, VL remedy, Hospitalization, Tests and other Treatment options) presented for the entire study population and per remedy method: inpatient and outpatient. Mean, regular deviation (sd), median, inter-quartile variety (IQR) are presented for each category, also as p-values linked to Mann-Whitney-Wilcoxon (MWW) test and bootstrapping final results for assessing the amount of power around the comparisons.Total (N = 127) Mean VL diagnosis Hospital Private VL treatment Hospital PHC Hospitalization Tests Hospital Private Other therapy Total Fees Price of a day in hospital* 42 11 31 49 21 27 309 148 120 28 47 594 33 (sd) (26) (12) (30) (10) (16) (19) (236) (369) (351) (39) (40) (544) (13) Median 38 0 36 49 15 31 262 75 48 13 58 520 32 (IQR) (2258) (02) (00) (4553) (1034) (04) (161376) (30128) (1297) (00) (43) (316658) (2240) 7 2 five eight three 5 52 25 20 five eight Mean 51 5 46 47 29 18 415 228 187 40 57 798 29 Inpatient (N = 73) (sd) (27) (9) (29) (12) (16) (18) (251) (472) (452) (45) (41) (637) (10) Median 40 0 39 47 27 21 357 116 85 22 64 636 28 (IQR) (3675) (0) (3675) (3952) (1536) (04) (273464) (84186) (39142) (44) (87) (548825) (1938) 6 0 six six 4 2 52 29 24 5 7 Imply 30 19 11 51 11 40 165 40 28 11 34 319 39 Outpatient (N = 54) (sd) (20) (11) (17) (5) (9) (13) (99) (34) (26) (18) (34) (134) (15) Median 23 22 0 52 9 43 154 35 23 0 21 307 36 (IQR) (2140) (2123) (06) (4954) (53) (3749) (95214) (1360) (75) (07) (32) (216416) (2945) 10 six 4 16 4 12 52 12 9 three 10 0.001 0.001 0.001 96.9 100 97.three 0.001 0.1359656-11-3 manufacturer 001 100 100 0.1256787-10-6 Formula 003 84.PMID:25040798 2 MWW Pvalue 0.001 Test power 100Note: VL remedy in the PHC consisted with the price tag of Glucantime and the personnel cost on the injection; capital and recurrent expenses could not be estimated. VL therapy at the hospital incorporated only the cost of Glucantime as personnel, capital and recurrent expenses were incorporated in the category “hospitalization”. *This is definitely the cost of a day in hospital excluding the charges from the diagnostic tests (e.g. serology, bone marrow aspirate) and treatment options (e.g. glucantime) precise to visceral leishmaniasis management. doi:10.1371/journal.pone.0155482.toutpatient method US 36 (imply of US 39) compare to inpatient hospitals US 28 (mean of US 29) (Table three). When the usage of all private resources was estimated at public unit price tag (scenario 2) the total median cost per VL patient was US 486 (mean of US 571). The differences between VL treatment techniques had been comparable to those observed in s.